A Multicenter Randomized Open-label Study of Oseltamivir Combined With High-dose Dexamethasone Versus High-dose Dexamethasone in the Management of Immune Thrombocytopenia
Phase of Trial: Phase II
Latest Information Update: 10 Dec 2019
Price : $35 *
At a glance
- Drugs Oseltamivir (Primary) ; Dexamethasone
- Indications Idiopathic thrombocytopenic purpura
- Focus Therapeutic Use
- 10 Dec 2019 Interim analysis results (n=59) presented at the 61st Annual Meeting and Exposition of the American Society of Hematology.
- 12 May 2019 Status changed from recruiting to completed.
- 13 Aug 2018 Planned End Date changed from 1 Dec 2017 to 1 Mar 2019.